Difference between revisions of "2018-02-21 FMG concall"

From HL7Wiki
Jump to navigation Jump to search
Line 44: Line 44:
 
*Discussion Topics
 
*Discussion Topics
 
**Freeze date evaluation
 
**Freeze date evaluation
 +
**[https://docs.google.com/document/d/1NHcWfTjnLZc36Rv6ALWRmluFhi-J2U8VysZsNRYcLng/edit IG risk mitigation]
 
**NIBs
 
**NIBs
 
**Policy around change deferral timeliens
 
**Policy around change deferral timeliens

Revision as of 19:37, 21 February 2018

HL7 TSC FMG Meeting Minutes

Location:
https://global.gotomeeting.com/join/279790597

(voice and screen)

Date: 2018-02-21
Time: 4:00 PM U.S. Eastern
Chair: Note taker(s): Anne W.
Quorum = chair + 4 yes/no
Co chairs David Hay Lloyd McKenzie
ex-officio . Wayne Kubick, CTO
Members Members Members Observers/Guests
Hans Buitendijk Brian Postlethwaite Paul Knapp Anne W., scribe
Josh Mandel John Moehrke Brian Pech
Grahame Grieve .

Agenda

  • Roll Call
  • Agenda Check
  • Minutes from 2018-02-14_FMG_concall
  • Action items
    • PA to consider other alternatives for PatientAnimal
    • John and Brian Post to work together to figure out how to express what Brian wants and compare it to what is already in Consent for review with Grahame and then FMG if necessary
    • Check with Grahame on implementation of distinguishing HL7 artifacts from others and controlling maintenance of the artifacts in the FHIR Registry
    • Lloyd/Grahame to work on Google doc to identify risks/strategies around universal realm IGs
    • Grahame to reach out to international council re: international IGs
    • Lloyd will draft an email to run past David and Grahame to address the issue of CBCP using Contract for Consent purposes
  • Review Items
  • Discussion Topics
  • Reports
    • Connectathon management (David/Brian)
    • SGB –
    • MnM –
    • FMG Liaisons
  • Process management
  • AOB (Any Other Business)

Minutes

Next Steps

Actions (Include Owner, Action Item, and due date)
Next Meeting/Preliminary Agenda Items

2018-02-28 FMG concall


Back to FHIR_Management_Group

© 2018 Health Level Seven® International